Effects of carbamates on whole blood cholinesterase activity: chemical protection against soman.
The toxicity (LD50) of several carbamates, all reversible inhibitors of cholinesterase (ChE), were determined in male rabbits. These include isopropyl methylphenyl carbamate (IMPC), pyridostigmine, neostigmine, benzpyrinium and physostigmine. When 1/9 of the LD50 of the above carbamates was individually combined with atropine (A) and benactyzine (B), mecamylamine (M) or chloropromazine (CPZ) and administered to rabbits in a pretreatment regimen, most animals could be protected from a 10 LD50 challenge of Soman. If CPZ, M or B was omitted from this regimen, no rabbits survived this challenge of Soman. The protection afforded against Soman was found to be related to reversible inhibition of ChE by the carbamates; reversible ChE inhibition varied with the route of injection and with the physical properties of the carbamate. Oral administration of pyridostigmine, a quaternary carbamate, provided protection for 24 hours. When the pretreatment included four components (pyridostigmine, A, M and B), the LD50 of Soman was raised 30.8 times in rabbits.
D000818:Animals; D002219:Carbamates / Q000494:pharmacology* / Q000633:toxicity; D002802:Cholinesterases / Q000097:blood*; D007928:Lethal Dose 50; D008297:Male; D009943:Organophosphorus Compounds / Q000037:antagonists & inhibitors*; D011729:Pyridostigmine Bromide / Q000494:pharmacology; D011817:Rabbits; D012999:Soman / Q000037:antagonists & inhibitors* / Q000633:toxicity
D002219:Carbamates; D009943:Organophosphorus Compounds; D012999:Soman; D002802:Cholinesterases; D011729:Pyridostigmine Bromide